Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease

[1]  Amy J. Jak,et al.  Differential age effects on cerebral blood flow and BOLD response to encoding: Associations with cognition and stroke risk , 2009, Neurobiology of Aging.

[2]  Lisa Delano-Wood,et al.  The Association of Smoking and Cardiovascular Disease in a Population With Low Cholesterol Levels: A Study of 648 346 Men From the Korean National Health System Prospective Cohort Study , 2008 .

[3]  I. Shapira.  The Nun Study. , 2008, Journal of the American Dental Association.

[4]  M. Albert.  Neuropsychology of Alzheimer's disease. , 2008, Handbook of clinical neurology.

[5]  Justin L. Vincent,et al.  Disruption of Large-Scale Brain Systems in Advanced Aging , 2007, Neuron.

[6]  Anders M. Dale,et al.  Feasibility of Multi-site Clinical Structural Neuroimaging Studies of Aging Using Legacy Data , 2007, Neuroinformatics.

[7]  R. Green,et al.  Vascular factors predict rate of progression in Alzheimer disease , 2007, Neurology.

[8]  J. Wixted,et al.  Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. , 2007, Neuropsychology.

[9]  Arthur F. Kramer,et al.  Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function , 2007, Trends in Cognitive Sciences.

[10]  V. Pankratz,et al.  A plateau in pre-Alzheimer memory decline , 2007, Neurology.

[11]  M. Bondi,et al.  Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease , 2007, Neuropsychology Review.

[12]  S. Riedel-Heller,et al.  Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  Richard Mayeux,et al.  Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.

[14]  F. Cuetos,et al.  Linguistic changes in verbal expression: A preclinical marker of Alzheimer's disease , 2007, Journal of the International Neuropsychological Society.

[15]  M. Albert,et al.  Longitudinal change in cognitive performance among individuals with mild cognitive impairment. , 2007, Neuropsychology.

[16]  Murray Grossman,et al.  Categorization of novel animals by patients with Alzheimer's disease and corticobasal degeneration. , 2007, Neuropsychology.

[17]  Lisa T. Eyler,et al.  Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response , 2007, Neurobiology of Aging.

[18]  Hui-Xin Wang,et al.  Brain reserve hypothesis in dementia. , 2007, Journal of Alzheimer's disease : JAD.

[19]  N. Raz,et al.  Differential Aging of the Brain: Patterns, Cognitive Correlates and Modifiers , 2022 .

[20]  S. Riedel-Heller,et al.  Mild cognitive impairment , 2006, Neurology.

[21]  R. Dean,et al.  TEST REVIEW: Dean C. Delis, Edith Kaplan & Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological Corporation, San Antonio, TX, 2001. $415.00 (complete kit) , 2006 .

[22]  Chris Zarow,et al.  Cognitive impact of subcortical vascular and Alzheimer's disease pathology , 2006, Annals of neurology.

[23]  G. Livingston,et al.  Relationship of vascular risk to the progression of Alzheimer disease , 2006, Neurology.

[24]  Howard J. Rosen,et al.  Multiple Cognitive Deficits in Amnestic Mild Cognitive Impairment , 2006, Dementia and Geriatric Cognitive Disorders.

[25]  B. Miller,et al.  Subtype of Mild Cognitive Impairment and Progression to Dementia and Death , 2006, Dementia and Geriatric Cognitive Disorders.

[26]  E. Twamley,et al.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease , 2006, Journal of the International Neuropsychological Society.

[27]  G. Chelune,et al.  Development of WAIS-III General Ability Index Minus WMS-III Memory Discrepancy Scores , 2006, The Clinical neuropsychologist.

[28]  D. Delis,et al.  Heterogeneity in Verbal Memory: A Marker of Preclinical Alzheimer's Disease? , 2006, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

[29]  J Philip Miller,et al.  Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI , 2006, Neurology.

[30]  Sara Rosenblum,et al.  Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. , 2006, Archives of general psychiatry.

[31]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[32]  R. Petersen,et al.  Cognitive measures predict pathologic Alzheimer disease. , 2006, Archives of neurology.

[33]  C. Vergani,et al.  Mild Cognitive Impairment Subtypes and Vascular Dementia in Community‐Dwelling Elderly People: A 3‐Year Follow‐Up Study , 2006, Journal of the American Geriatrics Society.

[34]  Hans Förstl,et al.  Prevalence and Persistence of Mild Cognitive Impairment among Elderly Patients in General Hospitals , 2006, Dementia and Geriatric Cognitive Disorders.

[35]  P. Zandi,et al.  Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study , 2006, Alzheimer disease and associated disorders.

[36]  Fabrizio Vernieri,et al.  Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease , 2006, Stroke.

[37]  W R Markesbery,et al.  Risk factors for transitions from normal to mild cognitive impairment and dementia , 2006, Neurology.

[38]  P. Scheltens,et al.  Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  Takashi Asada,et al.  Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography , 2006, Nuclear medicine communications.

[40]  L H Kuller,et al.  Neuropsychological characteristics of mild cognitive impairment subgroups , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  J. Hodges,et al.  Mild cognitive impairment: applicability of research criteria in a memory clinic and characterization of cognitive profile , 2006, Psychological Medicine.

[42]  J. Mortimer,et al.  Early-Life Risk Factors for Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[43]  H. Tuokko,et al.  Mild cognitive impairment : international perspectives , 2006 .

[44]  T. Sunderland,et al.  Apolipoprotein E and category fluency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease , 2005, Neuropsychologia.

[45]  D. Delis,et al.  Asymmetries in global-local processing ability in elderly people with the apolipoprotein E-ε4 allele , 2005 .

[46]  D. Delis,et al.  Deficits in Inhibition and Flexibility are Associated with the APOE-E4 Allele in Nondemented Older Adults , 2005, Journal of clinical and experimental neuropsychology.

[47]  Dean C Delis,et al.  Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: Verbal versus design fluency , 2005, Journal of the International Neuropsychological Society.

[48]  H. Damasio,et al.  The aging brain: The cognitive reserve hypothesis and hominid evolution , 2005, American journal of human biology : the official journal of the Human Biology Council.

[49]  R. Mayeux,et al.  Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. , 2005, Archives of neurology.

[50]  S. Marshall,et al.  Association between Recurrent Concussion and Late-Life Cognitive Impairment in Retired Professional Football Players , 2005, Neurosurgery.

[51]  Hilkka Soininen,et al.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.

[52]  L S Honig,et al.  Aggregation of vascular risk factors and risk of incident Alzheimer disease , 2005, Neurology.

[53]  J. Fisk,et al.  Outcomes of incident mild cognitive impairment in relation to case definition , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[54]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[55]  Lars Bäckman,et al.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. , 2005, Neuropsychology.

[56]  S Shaji,et al.  The Prevalence of Dementia , 2022 .

[57]  Gregory G. Brown,et al.  fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease , 2005, Neurology.

[58]  D. Delis,et al.  Asymmetry in Auditory and Spatial Attention Span in Normal Elderly Genetically At Risk for Alzheimer’s Disease , 2005, Journal of clinical and experimental neuropsychology.

[59]  D. Delis,et al.  Asymmetries in global-local processing ability in elderly people with the apolipoprotein e-epsilon4 allele. , 2005, Neuropsychology.

[60]  K. Jellinger.  Head injury and dementia , 2004, Current opinion in neurology.

[61]  R. Mayeux,et al.  Hyperinsulinemia and risk of Alzheimer disease , 2004, Neurology.

[62]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[63]  D. Bowers,et al.  Asymmetry of the hippocampus and amygdala in MRI volumetric measurements of normal adults , 2004, Journal of the International Neuropsychological Society.

[64]  R. Mayeux,et al.  Cardiovascular risk factors and Alzheimer’s disease , 2004, Current atherosclerosis reports.

[65]  L. Baxter,et al.  Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele , 2004, Neurology.

[66]  G. Chelune,et al.  Education-stratified base-rate information on discrepancy scores within and between the Wechsler Adult Intelligence Scale--Third Edition and the Wechsler Memory Scale--Third Edition. , 2004, Psychological assessment.

[67]  F. Lalonde,et al.  Context-specific memory and apolipoprotein E (ApoE) ε4: Cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease , 2004, Journal of the International Neuropsychological Society.

[68]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[69]  P. Amouyel,et al.  Commonalities between genetics of cardiovascular disease and neurodegenerative disorders , 2004, Current opinion in lipidology.

[70]  D. Selkoe,et al.  Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. , 2004, The American journal of pathology.

[71]  Faith M. Gunning-Dixon,et al.  Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume , 2004, Neurobiology of Aging.

[72]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[73]  C. Jack,et al.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. , 2004, Archives of neurology.

[74]  R. Mayeux,et al.  Stroke and the risk of Alzheimer disease. , 2003, Archives of neurology.

[75]  J. Bowler.  Epidemiology: Identifying Vascular Cognitive Impairment , 2003, International Psychogeriatrics.

[76]  Ronald C Petersen,et al.  Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease , 2003, Journal of the International Neuropsychological Society.

[77]  D. Delis,et al.  Neuropsychological deficits associated with Alzheimer's disease in the very-old: Discrepancies in raw vs. standardized scores , 2003, Journal of the International Neuropsychological Society.

[78]  K. Yaffe,et al.  A Longitudinal Study of Cardiorespiratory Fitness and Cognitive Function in Healthy Older Adults , 2003, Journal of the American Geriatrics Society.

[79]  R. Bucks,et al.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful , 2003, Journal of neurology, neurosurgery, and psychiatry.

[80]  Matthew P. Frosch,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  L. Bäckman,et al.  Cognitive deficits in preclinical Alzheimer's disease , 2003, Acta neurologica Scandinavica. Supplementum.

[82]  C. Iadecola,et al.  Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia , 2003, Stroke.

[83]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[84]  B. Reisberg,et al.  Vascular cognitive impairment , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[85]  D. Selkoe,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[86]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[87]  Douglas Galasko,et al.  Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype , 2002, Journal of the International Neuropsychological Society.

[88]  Erin D Bigler,et al.  Dementia, asymmetry of temporal lobe structures, and Apolipoprotein E genotype: Relationships to cerebral atrophy and neuropsychological impairment , 2002, Journal of the International Neuropsychological Society.

[89]  Roberto Cabeza,et al.  Aging Gracefully: Compensatory Brain Activity in High-Performing Older Adults , 2002, NeuroImage.

[90]  L. Thal,et al.  Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals , 2002, Neurology.

[91]  J Philip Miller,et al.  Rates of progression in mild cognitive impairment and early Alzheimer’s disease , 2002, Neurology.

[92]  J. Brewer,et al.  Imaging the medial temporal lobe: exploring new dimensions , 2002, Trends in Cognitive Sciences.

[93]  D. Delis,et al.  Do neuropsychological tests detect preclinical Alzheimer's disease: individual-test versus cognitive-discrepancy score analyses. , 2002, Neuropsychology.

[94]  J. C. Torre,et al.  Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .

[95]  S. Wisniewski,et al.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.

[96]  P. Zandi,et al.  Incidence of AD may decline in the early 90s for men, later for women , 2002, Neurology.

[97]  K. Jellinger,et al.  Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. , 2002, Neurology.

[98]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[99]  G. Chelune,et al.  WMS–III performance in patients with temporal lobe epilepsy: Group differences and individual classification , 2001, Journal of the International Neuropsychological Society.

[100]  G Ratcliff,et al.  Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. , 2001, Archives of general psychiatry.

[101]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[102]  C. Fennema-Notestine,et al.  Effects of age on tissues and regions of the cerebrum and cerebellum , 2001, Neurobiology of Aging.

[103]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[104]  M. Albert,et al.  Preclinical prediction of AD using neuropsychological tests , 2001, Journal of the International Neuropsychological Society.

[105]  J. Manfreda,et al.  Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. , 2001, International journal of epidemiology.

[106]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[107]  D. Delis,et al.  Do Subgroups of Patients With Alzheimers Disease Exhibit Asymmetric Deficits on Memory Tests? , 2001, Journal of clinical and experimental neuropsychology.

[108]  O Almkvist,et al.  Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment , 2001, Neuroreport.

[109]  C. Schweiger.  [Statins and the risk of dementia]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[110]  F Kruggel,et al.  Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly , 2001, Neurobiology of Aging.

[111]  A. Folsom,et al.  Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.

[112]  L. Fratiglioni,et al.  Stability of the preclinical episodic memory deficit in Alzheimer's disease. , 2001, Brain : a journal of neurology.

[113]  J. Lafrancois,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model Volume 7, Number 4 (2000), pages 321–331 , 2000, Neurobiology of Disease.

[114]  H. Arai,et al.  [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[115]  Paolo Vitali,et al.  Hippocampal perfusion in mild Alzheimer's disease , 2000, Psychiatry Research: Neuroimaging.

[116]  P. Riederer,et al.  Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains , 2000, International Journal of Developmental Neuroscience.

[117]  I G McKeith,et al.  MRI volumetric correlates of white matter lesions in dementia with lewy bodies and Alzheimer's disease , 2000, International journal of geriatric psychiatry.

[118]  EtsuroMori,et al.  Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease , 2000 .

[119]  E. Mori,et al.  Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease: A Quantitative Study , 2000, Stroke.

[120]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[121]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[122]  T. Ohnishi,et al.  Longitudinal Evaluation of Early Alzheimer's Disease Using Brain Perfusion Spect the Recruitment Was For , 2000 .

[123]  C. DeCarli,et al.  Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy , 2000, Neurology.

[124]  B. Winblad,et al.  The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. , 2000, Archives of neurology.

[125]  P. Maruff,et al.  The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment , 2000, Neuroscience & Biobehavioral Reviews.

[126]  M. Breteler.  Vascular Involvement in Cognitive Decline and Dementia: Epidemiologic Evidence from the Rotterdam Study and the Rotterdam Scan Study , 2000, Annals of the New York Academy of Sciences.

[127]  W. Markesbery,et al.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆ , 2000, Neurobiology of Aging.

[128]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[129]  F. Thibaut,et al.  Head trauma as a risk factor for schizophrenia , 2000, Schizophrenia Research.

[130]  C. DeCarli,et al.  Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[131]  S. Lovestone.  Diabetes and dementia , 1999, Neurology.

[132]  R. Doody,et al.  The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease. , 1999, Archives of neurology.

[133]  M. D’Esposito,et al.  The Effect of Normal Aging on the Coupling of Neural Activity to the Bold Hemodynamic Response , 1999, NeuroImage.

[134]  L. Thal,et al.  Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. , 1999, Psychology and aging.

[135]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[136]  D. Salat,et al.  Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. , 1999, Archives of neurology.

[137]  Q. Mu,et al.  A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. , 1999, AJNR. American journal of neuroradiology.

[138]  S. Sala,et al.  Unilateral Spatial Neglect in The Late Stage of Alzheimer's Disease , 1998, Cortex.

[139]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[140]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[141]  R. Kikinis,et al.  White matter changes with normal aging , 1998, Neurology.

[142]  J. Miller,et al.  A prospective study of cognitive function and onset of dementia in cognitively healthy elders. , 1998, Archives of neurology.

[143]  M. Margaglione,et al.  Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study. , 1998, Stroke.

[144]  B. Hyman,et al.  Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease. , 1998, Journal of Alzheimer's disease : JAD.

[145]  H. Braak,et al.  Evolution of Alzheimer's disease related cortical lesions. , 1998, Journal of neural transmission. Supplementum.

[146]  A. Ott.  Risk of dementia: The Rotterdam Study , 1997 .

[147]  R. Doody,et al.  Neuropsychological asymmetry in Alzheimer's disease: Verbal versus visuoconstructional deficits across stages of dementia , 1997, Journal of the International Neuropsychological Society.

[148]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[149]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[150]  N. Relkin,et al.  Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.

[151]  J. Démonet,et al.  Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[152]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[153]  C. Kawas,et al.  Learning and retention in preclinical and early Alzheimer's disease. , 1997, Psychology and aging.

[154]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[155]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[156]  D. Salmon,et al.  The Neuropsychology of Alzheimer’s Disease , 1997 .

[157]  C. Degueldre,et al.  Functional anatomy of verbal and visuospatial span tasks in Alzheimer's disease , 1997, Human brain mapping.

[158]  Victor W. Henderson,et al.  Memory span procedures in Alzheimer's disease. , 1996 .

[159]  G. Small,et al.  Predictors of cognitive change in middle-aged and older adults with memory loss. , 1995, The American journal of psychiatry.

[160]  N Butters,et al.  Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults , 1995, Neurology.

[161]  J. Brandt,et al.  Instability of cognitive asymmetry in Alzheimer's disease. , 1995, Journal of clinical and experimental neuropsychology.

[162]  P. Satz,et al.  Heterogeneity of cognitive profiles in normal aging: implications for early manifestations of Alzheimer's disease. , 1995, Journal of clinical and experimental neuropsychology.

[163]  K. Marder,et al.  Neuropsychological detection and characterization of preclinical Alzheimer's disease , 1995, Neurology.

[164]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[165]  L. Wilkins.  Dementia: A Clinical Approach, 2nd Ed. , 1995 .

[166]  J C Mazziotta,et al.  Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.

[167]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[168]  F Fazio,et al.  Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. , 1995, Dementia.

[169]  D. Mathalon,et al.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. , 1994, Archives of neurology.

[170]  C. Grady,et al.  Reduction of Functional Neuronal Connectivity in Long‐term Treated Hypertension , 1994, Stroke.

[171]  Claudia H. Kawas,et al.  The epidemiology of dementia and Alzheimer disease. , 1994 .

[172]  A. Monsch,et al.  Preclinical cognitive markers of dementia of the Alzheimer type. , 1994 .

[173]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[174]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[175]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[176]  R B D'Agostino,et al.  Incidence of dementia and probable Alzheimer's disease in a general population , 1993, Neurology.

[177]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[178]  E. Masliah,et al.  Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.

[179]  Richard Barnett,et al.  Diabetes mellitus. , 1993, The Medical journal of Australia.

[180]  Robert P. Friedland,et al.  Dementia: A Clinical Approach (2nd Ed.) , 1992 .

[181]  S. McPherson,et al.  Cognitive performance in relatives of patients with probable Alzheimer disease: an age at onset effect? , 1992, Journal of clinical and experimental neuropsychology.

[182]  D. Delis,et al.  Spatial cognition in Alzheimer's disease: subtypes of global-local impairment. , 1992, Journal of clinical and experimental neuropsychology.

[183]  J V Haxby,et al.  Visuospatial attention in dementia of the Alzheimer type. , 1992, Brain : a journal of neurology.

[184]  N Butters,et al.  Directed and divided attention in Alzheimer's disease: impairment in shifting of attention to global and local stimuli. , 1992, Journal of clinical and experimental neuropsychology.

[185]  R. D'Agostino,et al.  Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study , 1992, Neurology.

[186]  C. Bouras,et al.  Asymmetrical cerebral atrophy in Alzheimer's disease. , 1991, Clinical neuropathology.

[187]  A. Heyman,et al.  Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991 .

[188]  A Hofman,et al.  Risk Factors for Alzheimer's Disease: Overview of the EURODEM Collaborative Re-Analysis of Case-Control Studies , 1991 .

[189]  L. Fratiglioni,et al.  Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991, International journal of epidemiology.

[190]  J. Haxby,et al.  Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. , 1990, Archives of neurology.

[191]  D. Salmon,et al.  The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.

[192]  Myrna F. Schwartz,et al.  Modular deficits in Alzheimer-type dementia , 1990 .

[193]  A. J. Fridlund,et al.  Visuospatial dysfunction following unilateral brain damage: dissociations in hierarchical and hemispatial analysis. , 1988, Journal of clinical and experimental neuropsychology.

[194]  J. Haxby,et al.  Relations between Neuropsychological and Cerebral Metabolic Asymmetries in Early Alzheimer's Disease , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[195]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[196]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[197]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .